Atlas Trials

Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer

Clinical trial NCT00299286 · COMPLETED

Trial details

NCT number
NCT00299286
Sponsor
Institute of Cancer Research, United Kingdom
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2007-06-01
Primary completion
2011-08-01
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.